EMA — authorised 2 June 1998
- Marketing authorisation holder: Roche Registration GmbH
- Status: approved
🇪🇺 Mabthera in European Union
EMA authorised Mabthera on 2 June 1998
Marketing authorisation
Mabthera in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in European Union
Frequently asked questions
Is Mabthera approved in European Union?
Yes. EMA authorised it on 2 June 1998.
Who is the marketing authorisation holder for Mabthera in European Union?
Roche Registration GmbH holds the EU marketing authorisation.